The federal government will oversee a centralized system to order, distribute, and track COVID-19 vaccines. All vaccines will be ordered through CDC. Vaccine providers will receive vaccines from CDC’s centralized distributor or directly from a vaccine manufacturer.
Two vaccines are authorized and recommended to prevent COVID-19 in the United States, other COVID-19 vaccine candidates are in development, and clinical trials are being conducted at the same time with large-scale manufacturing. With first doses now available, planning and preparing for a COVID-19 vaccination program is very important.
Planning efforts have focused on every step and detail of the process, including:
- Establishing and testing logistics plans with manufacturers and commercial partners that are part of CDC’s centralized COVID-19 vaccine delivery system
- Coordinating the first distribution of vaccines and needed supplies from centralized locations
- Ordering processes for additional doses of the vaccine after the first supply has been shipped
- Receiving, storing, and handling vaccines properly at very specific temperatures
- Deciding who should receive a vaccine first, based on national and state recommendations, if there are not enough doses of the vaccine for everyone
- Giving the vaccines in a safe way during an ongoing pandemic
- Reporting on vaccine inventory, administration, and safety using a variety of new and enhanced data systems
- Expanding safety surveillance through new systems and additional information sources, as well as scaling up existing safety monitoring systems
- Developing plans to assess vaccine effectiveness, which means how well the vaccines protect against COVID-19 under real-life conditions
- Making sure timely, credible, and clear communication is provided to the public and stakeholders around all aspects of the vaccination program
This situation continues to change, and planning will progress as more information about any authorized or approved vaccines becomes available. A safe and effective COVID-19 vaccine is a critical component of the U.S. strategy to reduce COVID-19-related illnesses, hospitalizations, and deaths and to help society function as it did before COVID-19. The goal of the U.S. government is to have enough COVID-19 vaccine doses for all people in the United States who choose to be vaccinated.